Dr. Charis Eng joined The Ohio State University in 1999. She served as Associate Professor of Medicine and Director of the Clinical Cancer Genetics Program in OSU. In 2001, Dr. Charis Eng was granted the Davis Professorship and selected as Co-Director of the Division of Human Genetics in the Department of Internal Medicine. In 2002, she became Professor and Division Director, and was granted as the Klotz Endowed Chair.

“Her work at OSU uses acid- and protein-based work to identify, characterize, and understand genes that cause susceptibility to inherited cancer syndromes and to determine how these genes can be used to develop new clinical applications. As a result of these studies, Dr. Eng was the first in the world to map and identify PTEN, the gene that codes for a tumor suppressor phosphotase on chromosome 10. This has proven to be a major factor in determining susceptibility for Cowden syndrome and other related diseases. She has conducted extensive research on characterizing PTEN, showing that it suppresses tumor growth.”

Bibliography:

• “Staff Display.” Charis Eng, MD, PhD. N.p., n.d. Web. 20 Apr. 2016
• “Biography – Charis Eng, MD (Ohio).” U.S National Library of Medicine. U.S. National Library of Medicine, n.d. Web. 20 Apr. 2016.